#BioTime Inc (BTX)

AGENUS Agenus (AGEN)  announced the upcoming launch of its Biotech Electronic Security Token (BEST);  the first digital security offering in healthcare. Tokenization enables qualified investors to dir...

REGENERON (REGN)  agreed to settle with Genentech over Its eye drug Eylea. Regeneron will make $60 payment to Genentech when cumulative U.S. sales of Eylea reach $400 million. It also will pay royalti...

SEQUENOM (SQNM) Ordering The Firm’s MaterniT21 laboratory-developed Test (LDT) In the News, numerous leading healthcare providers across the United States, including Women & Infants Hospital of Rhode...